Sevoflurane- and desflurane-induced human myocardial post-conditioning through Phosphatidylinositol-3-kinase/Akt signalling

Acta Anaesthesiol Scand. 2009 Aug;53(7):949-56. doi: 10.1111/j.1399-6576.2009.02009.x. Epub 2009 Jun 3.

Abstract

Background: The role of phosphatidylinositol-3-kinase (PI3K) in sevoflurane- and desflurane-induced myocardial post-conditioning remains unknown.

Methods: We recorded isometric contraction of isolated human right atrial trabeculae (oxygenated Tyrode's at 34 degrees C, stimulation frequency 1 Hz). In all groups, a 30-min hypoxic period was followed by a 60-min reoxygenation period. At the onset of reoxygenation, muscles were exposed to 5 min of sevoflurane 1%, 2%, and 3%, and desflurane 3%, 6%, and 9%. In separate groups, sevoflurane 2% and desflurane 6% were administered in the presence of 100 nM wortmannin, a PI3K inhibitor. Recovery of force after the 60-min reoxygenation period was compared between groups (mean +/- SD).

Result: As compared with the Control group (49 +/- 7% of baseline) PostC by sevoflurane 1%, 2%, and 3% (78 +/- 4%, 79 +/- 5%, and 85 +/- 4% of baseline, respectively) and desflurane 3%, 6%, and 9% (74 +/- 5%, 84 +/- 4%, and 86 +/- 11% of baseline, respectively) enhanced the recovery of force. This effect was abolished in the presence of wortmannin (56 +/- 5% of baseline for sevoflurane 2%+wortmannin; 56 +/- 3% of baseline for desflurane 6%+wortmannin). Wortmannin alone had no effect on the recovery of force (57 +/- 7% of baseline).

Conclusion: In vitro, sevoflurane and desflurane post-conditioned human myocardium against hypoxia through activation of phosphatidylinositol-3-kinase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Androstadienes / pharmacology
  • Anesthetics, Inhalation / pharmacology*
  • Desflurane
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Female
  • Heart / drug effects*
  • Heart / physiology*
  • Heart Atria
  • Humans
  • Hypoxia / physiopathology
  • In Vitro Techniques
  • Ischemic Preconditioning, Myocardial*
  • Isoflurane / analogs & derivatives*
  • Isoflurane / pharmacology
  • Male
  • Methyl Ethers / pharmacology*
  • Middle Aged
  • Myocardium / enzymology*
  • Oncogene Protein v-akt / metabolism
  • Oncogene Protein v-akt / physiology*
  • Organ Size / physiology
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphatidylinositol 3-Kinases / physiology*
  • Phosphoinositide-3 Kinase Inhibitors
  • Preanesthetic Medication
  • Sevoflurane
  • Signal Transduction / drug effects*
  • Wortmannin

Substances

  • Androstadienes
  • Anesthetics, Inhalation
  • Enzyme Inhibitors
  • Methyl Ethers
  • Phosphoinositide-3 Kinase Inhibitors
  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Oncogene Protein v-akt
  • Wortmannin